Application Disclosures Containing Nucleotide and/or Amino Acid Sequences | Midpage

Collections
Code of Federal Regulations

ECFRb728f1c2b6be0c1

Application Disclosures Containing Nucleotide and/or Amino Acid Sequences

1.821Nucleotide and/or amino acid sequence disclosures in patent applications.1.822Symbols and format to be used for nucleotide and/or amino acid sequence data.1.823Requirements for content of a “Sequence Listing” part of the specification.1.824Form and format for a nucleotide and/or amino acid sequence submission as an ASCII plain text file.1.825Amendment to add or replace a “Sequence Listing” and CRF copy thereof.1.831Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures.1.832Representation of nucleotide and/or amino acid sequence data in the “Sequence Listing XML” part of a patent application filed on or after July 1, 2022.1.833Requirements for a “Sequence Listing XML” for nucleotide and/or amino acid sequences as part of a patent application filed on or after July 1, 2022.1.834Form and format for nucleotide and/or amino acid sequence submissions as the “Sequence Listing XML” in patent applications filed on or after July 1, 2022.1.835Amendment to add or replace a “Sequence Listing XML” in patent applications filed on or after July 1, 2022.1.839Incorporation by reference.Appendix A to Subpart G of Part 1List of Nucleotides Appendix B to Subpart G of Part 1List of Modified Nucleotides Appendix C to Subpart G of Part 1List of Amino Acids Appendix D to Subpart G of Part 1List of Modified and Unusual Amino Acids Appendix E to Subpart G of Part 1List of Feature Keys Related to Nucleotide Sequences Appendix F to Subpart G of Part 1List of Feature Keys Related to Protein Sequences Appendix G to Subpart G of Part 1Numeric Identifiers